Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Kursexplosion von 383 % seit November und massiver Solana-Outperformer!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CRRX | ISIN: CA9411881043 | Ticker-Symbol: WWT
Tradegate
20.01.25
16:06 Uhr
0,006 Euro
+0,001
+10,00 %
1-Jahres-Chart
WATER WAYS TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
WATER WAYS TECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0030,00814:59
0,0040,00708:00
GlobeNewswire (Europe)
828 Leser
Artikel bewerten:
(2)

Water Ways Technologies Inc.: Water Ways Reports Q1 2024 Financial Results: Sales of CAD$2.3M and Net Loss of CAD$0.2M

Finanznachrichten News

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

TORONTO, May 31, 2024 (GLOBE NEWSWIRE) -- Water Ways Technologies Inc. (TSXV: WWT) (FRA: WWT) ("Water Ways" or the "Company"), a global provider of Israeli-based agriculture technology, providing water irrigation solutions to agricultural producers, announces the filing of its Interim Financial Statements (the "Statements") and Managements Discussion and Analysis (the "MD&A") for the three months period ended March 31, 2024. A comprehensive discussion of Water Ways' financial position and results of operations is provided in the MD&A, filed on SEDAR (www.sedar.com)

Mr. Ohad Haber, CEO and Chairman of the Board of Water Ways states: "The first quarter of 2024 shows the shift in our strategy. Over 90% of our revenues were derived from the Canadian market. In the coming months we also hope to increase our project revenue in Canada and improve our margins."

Highlights - Q1, 2024 (the following information should be read in conjunction with, and is qualified by, the Statements and the MD&A)

  • Company's sales were CAD$2.3M for the three months period ended March 31, 2024, compared to CAD$4.1M for three months period ended March 31, 2023.
  • Company's net loss was CAD$0.2M for the three months period ended March 31, 2024, compared to a net profit of CAD$0.4M in the three months period ended March 31, 2023.
  • Company's Gross Margin was 17.3% for the three months period ended March 31, 2024, compared to a Gross Margin of 21.5% in the three months period ended March 31, 2023.
  • Derivative Liability - Warrants and Convertible Debentures relates to a classification under IFRS of outstanding warrants issued as part of private placements of Convertible Debentures units and equity units which closed in the fiscal year 2021, 2022 and 2023, as a non-cash liability that arises due to the difference in operational currency and functional currency. This liability is revalued each period by an independent third party. The revaluation is at fair value through profit and loss.

Water Ways Technologies Financial Results Summary (CAD$ in thousands)

The following tables set forth the highlights of the consolidated financial information of the Company and should be read in conjunction with the Statements and the notes thereto.

(CAD in thousands) As of March 31,
2024
As of December 31,
2023
Change %
Balance Sheet Items:
Cash and Cash Equivalents289 199 45.2%
Total Current Assets 4,279 3,700 15.6%
Total Assets 4,934 4,447 11.0%
Total Current Liabilities 5,308 4,550 16.7%
Total Non-Current Liabilities 1,436 1,522 -5.7%
(CAD in thousands) For the three month period ended March 31,
2024 2023 Change %
Revenues:
Services Projects 160 491 -67.4%
Products 1,529 2,549 -40.0%
Total Revenues 1,689 3,040 -44.4%
Cost of Sales 1,397 2,385 -41.4%
Gross Profit 292 655 -55.4%
Gross Profit Margin % 17.3% 21.5%
Operating Expenses 417 699
Revaluation of derivatives(51) (418)
Financial expense (income), net 70 98
Taxes on Income (recovery)- -
Loss for the period (144) 276

About Water Ways Technologies Inc.
WWT through its subsidiaries, is a global provider of Israeli-based agriculture technology, providing water irrigation solutions to agricultural producers. WWT competes in the global irrigation water systems market with a focus on developing solutions with commercial applications in the micro and precision irrigation segments of the overall market. At present, WWT's main revenue streams are derived from the following business units: (i) Projects Business Unit; and (ii) Component and Equipment Sales Unit. WWT is capitalizing on the opportunities presented by micro and smart irrigation, while also making a positive mark on society by making these technologies more widely available, especially in developing markets such as Africa and Latin America and developed markets such as China and Canada. WWT's irrigation projects include vineyards, Cotton fields, Apple and Orange orchards, Blueberry, Medical Cannabis growers, fresh produce cooling rooms and more, in over fifteen countries.

For more information, please contact

Ronnie Jaegermann
Director
T: +972-54-4202054
E: ronnie@waterwt.com

https://www.water-ways-technologies.com/

https://www.hg-wwt.com/

Twitter: @WaterWaysTechn1

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements
Certain statements contained in this press release constitute "forward-looking information" as such term is defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", "will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions as they relate to Water Ways. All statements other than statements of historical fact may be forward-looking information. Such statements reflect Water Ways' current views and intentions with respect to future events, and current information available to Water Ways, and are subject to certain risks, uncertainties and assumptions. Material factors or assumptions were applied in providing forward-looking information. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. Should any factor affect Water Ways in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, Water Ways does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and Water Ways undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law. Water Ways' results and forward-looking information and calculations may be affected by fluctuations in exchange rates and its own share prices. All figures are in Canadian dollars unless otherwise indicated.


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.